Market revenue in 2023 | USD 1,894.9 million |
Market revenue in 2030 | USD 2,678.2 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.55% in 2023. Horizon Databook has segmented the North America crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
North America emerged as one of the prominent regional markets in 2023 and is expected to grow at a lucrative rate over the forecast period. Its growth can be attributed to the increasing need for pain management drugs and the increasing prevalence of headaches & migraine in the region.
According to an article published by the American Migraine Foundation in January 2021, more than 4 million adults in the U.S. suffer from chronic daily migraine, with a minimum of 15 headache days per month.
The increasing disposable income and expanding patient pool in the region are expected to drive market growth. A wide application of acetaminophen is likely to strengthen the presence & demand for various dosage forms and strengths of drugs, creating opportunities for players.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America crocin market , including forecasts for subscribers. This continent databook contains high-level insights into North America crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account